Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-26 @ 3:11 AM
Study NCT ID:
NCT01323920
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2011-03-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05
Start Date Type:
None
Primary Completion Date:
2013-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-24
First Submit QC Date:
None
Study First Post Date:
2011-03-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-02-14
Results First Submit QC Date:
None
Results First Post Date:
2014-03-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-23
Last Update Post Date:
2017-05-30
Last Update Post Date Type:
ACTUAL